Cellular Biomedicine Group, Inc. EPS - Earnings per Share 2010-2020 | CBMG
Cellular Biomedicine Group, Inc. eps - earnings per share from 2010 to 2020. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Cellular Biomedicine Group, Inc. Annual EPS |
2019 |
$-2.63 |
2018 |
$-2.20 |
2017 |
$-1.78 |
2016 |
$-2.09 |
2015 |
$-1.70 |
2014 |
$-1.79 |
2013 |
$-2.38 |
2012 |
$-2.24 |
2011 |
$-0.50 |
2010 |
$0.00 |
2009 |
$-0.01 |
Cellular Biomedicine Group, Inc. Quarterly EPS |
2020-09-30 |
$-0.88 |
2020-06-30 |
$-0.70 |
2020-03-31 |
$-0.60 |
2019-12-31 |
$-0.67 |
2019-09-30 |
$-0.82 |
2019-06-30 |
$-0.63 |
2019-03-31 |
$-0.51 |
2018-12-31 |
$-0.44 |
2018-09-30 |
$-0.72 |
2018-06-30 |
$-0.53 |
2018-03-31 |
$-0.51 |
2017-12-31 |
$-0.49 |
2017-09-30 |
$-0.43 |
2017-06-30 |
$-0.43 |
2017-03-31 |
$-0.43 |
2016-12-31 |
$-0.47 |
2016-09-30 |
$-0.75 |
2016-06-30 |
$-0.52 |
2016-03-31 |
$-0.35 |
2015-12-31 |
$-0.43 |
2015-09-30 |
$-0.44 |
2015-06-30 |
$-0.44 |
2015-03-31 |
$-0.39 |
2014-12-31 |
$-0.57 |
2014-09-30 |
$-0.31 |
2014-06-30 |
$-0.85 |
2014-03-31 |
$-0.06 |
2013-12-31 |
$-0.87 |
2013-09-30 |
$0.09 |
2013-06-30 |
$-0.44 |
2013-03-31 |
$-1.16 |
2012-12-31 |
$-1.17 |
2012-09-30 |
$-0.45 |
2012-06-30 |
$-0.30 |
2012-03-31 |
$-0.32 |
2011-12-31 |
$-0.50 |
2011-09-30 |
$-0.00 |
2011-06-30 |
$0.00 |
2011-03-31 |
$0.00 |
2010-12-31 |
$0.00 |
2010-09-30 |
$0.00 |
2010-06-30 |
$0.00 |
2010-03-31 |
$0.00 |
2009-12-31 |
$0.00 |
2009-09-30 |
$0.00 |
2009-06-30 |
$0.00 |
2009-03-31 |
$0.00 |